Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02733393 · ClinicalTrials.gov registry record · Phase 1
Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy
A Phase 1 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT02733393: Completed Phase 1 study, sponsored by NYU Langone Health.
NCT02733393 is a Phase 1 study that has completed, run by NYU Langone Health. The registered enrollment target is 2 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02733393, a Phase 1 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) after thoracotomy. This will be an open label preliminary pilot study to determine if SPG block has potential utility to manage ISP in post-thoracotomy patients. The primary outcome variable will be reduction of shoulder pain.
Primary Outcome
Patients will be followed after the SPG block(s) and the duration of pain relief will be monitored by serial assessments of the VAS. This assessment will occur for the initial SPG block and for all follow-up blocks, if performed.
Interventions
- DRUG lidocaine
- PROCEDURE Sphenopalatine Ganglion (SPG) Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-09-05 |
| Phase | Phase 1 |
What the finished NCT02733393 record still lists
NCT02733393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which lidocaine is the first listed.
NCT02733393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02733393 about?
NCT02733393 is a clinical study titled "Sphenopalatine Ganglion Block to Treat Shoulder Pain After Thoracotomy". The purpose of this pilot study is to evaluate the utility of sphenopalatine ganglion (SPG) block to manage ipsilateral shoulder pain (ISP) after thoracotomy. This will be an open label preliminary pilot study to determine if SPG block has potential utility to manage ISP in post-thoracotomy patients...
What is the current status of trial NCT02733393?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2015-09. Estimated completion is 2017-09-05.
What interventions are being tested in trial NCT02733393?
The interventions under investigation include: lidocaine (DRUG), Sphenopalatine Ganglion (SPG) Block (PROCEDURE).
Who is sponsoring clinical trial NCT02733393?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02733393's enrollment target sits among peer trials
2 2000th of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia